亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

医学 慢性肉芽肿性疾病 内科学 移植 造血干细胞移植 梅尔法兰 回顾性队列研究 免疫学 外科
作者
Jennifer W. Leiding,Danielle E. Arnold,Suhag H Parikh,Brent R. Logan,Rebecca A. Marsh,Linda M. Griffith,Ruizhe Wu,Sharon A. Kidd,Kanwaldeep K. Mallhi,Deepak Chellapandian,Stephanie Si Lim,Eyal Grunebaum,Emilia Liana Falcone,Luis E. Murguía-Favela,Debbi Grossman,Vinod K. Prasad,Jennifer R. Heimall,Fabien Touzot,Lauri M. Burroughs,Jack Bleesing
出处
期刊:Blood [Elsevier BV]
卷期号:142 (24): 2105-2118 被引量:28
标识
DOI:10.1182/blood.2022019586
摘要

Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening infections and inflammatory conditions. Hematopoietic cell transplantation (HCT) is the definitive treatment for CGD, but questions remain regarding patient selection and impact of active disease on transplant outcomes. We performed a multi-institutional retrospective and prospective study of 391 patients with CGD treated either conventionally (non-HCT) enrolled from 2004 to 2018 or with HCT from 1996 to 2018. Median follow-up after HCT was 3.7 years with a 3-year overall survival of 82% and event-free survival of 69%. In a multivariate analysis, a Lansky/Karnofsky score <90 and use of HLA-mismatched donors negatively affected survival. Age, genotype, and oxidase status did not affect outcomes. Before HCT, patients had higher infection density, higher frequency of noninfectious lung and liver diseases, and more steroid use than conventionally treated patients; however, these issues did not adversely affect HCT survival. Presence of pre-HCT inflammatory conditions was associated with chronic graft-versus-host disease. Graft failure or receipt of a second HCT occurred in 17.6% of the patients and was associated with melphalan-based conditioning and/or early mixed chimerism. At 3 to 5 years after HCT, patients had improved growth and nutrition, resolved infections and inflammatory disease, and lower rates of antimicrobial prophylaxis or corticosteroid use compared with both their baseline and those of conventionally treated patients. HCT leads to durable resolution of CGD symptoms and lowers the burden of the disease. Patients with active infection or inflammation are candidates for transplants; HCT should be considered before the development of comorbidities that could affect performance status. This trial was registered at www.clinicaltrials.gov as #NCT02082353.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
7秒前
9秒前
12秒前
喷火球发布了新的文献求助10
13秒前
爆米花的应助被宜兴彭于晏采纳,获得10
19秒前
29秒前
小巧的寒烟完成签到,获得积分10
42秒前
喷火球完成签到,获得积分10
42秒前
打打的应助被宜兴彭于晏采纳,获得10
43秒前
高兴的梦槐完成签到,获得积分10
44秒前
49秒前
49秒前
wanci的应助被宜兴彭于晏采纳,获得10
55秒前
慕青的应助被宜兴彭于晏采纳,获得10
1分钟前
1分钟前
风中的世平完成签到,获得积分10
1分钟前
1分钟前
直率的大门完成签到,获得积分10
1分钟前
1分钟前
1分钟前
Criminology34的应助被科研通管家采纳,获得10
1分钟前
Criminology34的应助被科研通管家采纳,获得10
1分钟前
Criminology34的应助被科研通管家采纳,获得10
1分钟前
慕青的应助被科研通管家采纳,获得10
1分钟前
zzzy完成签到 ,获得积分10
1分钟前
TingtingGZ发布了新的文献求助10
1分钟前
kholmes完成签到,获得积分10
1分钟前
1分钟前
Ava的应助被宜兴彭于晏采纳,获得30
1分钟前
1分钟前
顾矜的应助被兰斯洛特117采纳,获得10
2分钟前
朴素幻嫣完成签到,获得积分10
2分钟前
成就迎波完成签到,获得积分10
2分钟前
2分钟前
眼睛大淇完成签到,获得积分10
2分钟前
英俊的铭的应助被宜兴彭于晏采纳,获得10
2分钟前
彪壮的从阳完成签到,获得积分10
2分钟前
2分钟前
欣心完成签到,获得积分10
2分钟前
缥缈盼波完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173155
求助须知:如何正确求助?哪些是违规求助? 9565541
关于积分的说明 21780458
捐赠科研通 7767214
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476682